To elucidate the mechanisms of reduction of left ventricular end-diastolic pressure by nifedipine in certain individuals, we evaluated cardiac and peripheral hemodynamic responses in 32 patients after they were randomly assigned to nifedipine (20 mg sublingually) or to placebo treatment. Forearm plethysmography was performed during cardiac catheterization with micromanometers. No hemodynamic parameters were changed after placebo. Left ventricular end-diastolic pressure declined by 14% (p < .02) after nifedipine in patients with impaired left ventricular function, but was unchanged in those with normal function; indexes of peripheral venous hemodynamics (forearm venous tone, forearm volume change) were not affected. In those patients with abnormal left ventricular function, forearm vascular resistance decreased 36% and forearm blood flow increased 31% (p < .0005 for both), while neither changed in those with normal function. Cardiac output increased by 10% in patients with impaired left ventricular function but was unchanged in the remainder, while calculated total systemic resistance fell by 24% in those with abnormal left ventricular function (p < .002 for both). Thus, reduction of left ventricular preload by nifedipine is not attributable to venous pooling, but rather this beneficial effect appears to be attributable to improved left ventricular systolic function in response to afterload reduction, particularly in patients with impaired left ventricular function. Circulation 69, No. 5, 963-972, 1984. 
NIFEDIPINE reduces left and right ventricular enddiastolic pressures in patients with impaired left ventricular function,'4 but does not alter the filling pressures of those with normal left ventricular function." 2. 7 Although vasodilatation of the peripheral venous bed with a nitroglycerin-like venous pooling effect has been suggested as the mechanism for these changes in right and left ventricular filling pressures, l 2no direct evidence to support this speculation has been reported. Improved forward cardiac output3' has also been suggested as a mechanism for the reduction of filling pressures, again without validation.
Relaxation of peripheral vascular smooth muscle by nifedipine has been well documented. The few measurements of arterial dynamics in man8-'0 demonstrate dilation and increased flow. The limited data pertaining to changes in venous dynamics in man8' 10. are inconclusive. Accordingly, our study was designed to define the mechanisms responsible for nifedipine-induced reduction of right and left ventricular filling pressures in patients with impaired left ventricular function, and for the differential responses in patients with normal and abnormal left ventricular function. Direct measurement of the pressure, flow, and volume characteristics of the peripheral arterial and venous beds of patients was performed simultaneously with measurement of central hemodynamics during diagnostic cardiac catheterization.
Methods
Patient selection. Subjects were selected from those undergoing scheduled diagnostic cardiac catheterization for evaluation of chest pain. Entry criteria included the presence of normal sinus rhythm and the absence of acute myocardial infarction (within the preceding 3 months), valvular heart disease, peripheral vascular disease, or the need for uninterrupted therapy with long-acting nitrates or 3-blocking drugs.
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All therapy with cardioactive medications was tapered gradually and withdrawn completely at least 24 hr before each study. The protocol was approved by the Washington University School of Medicine Institutional Review Board, and written informed consent was obtained from all patients before their inclusion. Patients were assigned to receive either nifedipine or an identical-appearing placebo by random number code.
Cardiac catheterization and experimental protocol. Cardiac catheterization was performed with the use of the percutaneous femoral approach in subjects in the fasting state and premedicated with 0.75 mg/kg im hydroxyzine hydrochloride 1 hr before the procedure. In each patient right and left heart hemodynamics and cardiac output (Fick or indicator-dilution technique) were measured first. A No. 6F micromanometer catheter (Millar Instruments, Inc.) was advanced to the left ventricle via the left femoral artery with the use of an arterial introducer equipped with a side port through which arterial pressure was measured continuously. A No. 7F angiographic pigtail catheter was advanced to the left ventricle via the right femoral artery. Catheters were positioned carefully to avoid trabecular entrapment of the micromanometer tip and to avoid stimulation of ventricular ectopic beats. Left ventriculography was performed in the right anterior oblique projection, patients being instructed to retain a submaximal inspiration and to avoid the Valsalva maneuver. Contrast injection was performed with the use of a triggered injector (Medrad Mark 4); 40 ml of sodium and meglumine iothalamate (Vascoray) was injected at a rate of 12 ml/ sec. Left ventricular high-fidelity pressure and volume, as well as right ventricular pressure, were recorded simultaneously during the ventriculographic examination, as described previously. 1 12 After a pause of at least 15 min to permit dissipation of the effects of the contrast material,'3 intracardiac pressure and cardiac output measurements were repeated. Baseline plethysmographic data were recorded. Nifedipine (20 mg) or placebo was then administered by opening one end of the fluid-filled capsule and applying the contents beneath the subject's tongue; the subject was instructed to retain the solution sublingually for as long as possible without swallowing. Plethysmographic recordings were then repeated at S min intervals for 25 min, with simultaneous recordings of intracardiac, arterial, and venous pressures. After 30 min, at which time the full nifedipine effect was observed,' complete pressure and cardiac output recordings were repeated. The left ventriculographic examination was then repeated under conditions identical to those extant during the recording of the initial left ventriculogram, with simultaneous measurement of high-fidelity left ventricular pressures and volume. Left ventriculography in the left anterior oblique projection was performed to ascertain the presence and extent of asynergic contractions. Selective coronary arteriography was performed with the use of preshaped catheters.
Plethysmography. Forearm venous occlusion strain-gauge plethysmography was used to permit monitoring of peripheral arterial and venous hemodynamics. Techniques developed by Whitney,'4 Mason and Braunwald,'5 and Zelis et al.'6 were adapted to allow monitoring of peripheral hemodynamics during sterile cardiac catheterization procedures. A commercially available mercury-in-rubber strain-gauge plethysmograph (Hokanson EC-4) was used to measure changes in forearm volumes. Peripheral arterial hemodynamics were expressed in terms of forearm blood flow and forearm vascular resistance. Acute occlusion of forearmn venous return was achieved by inflation of a sphygmomanometric cuff placed on the upper arm to a pressure greater than venous but less than arterial diastolic pressure (30 to 40 mm Hg). With this occlusion, forearm volume increased at a rate proportional to arterial inflow, which became progressively impeded as the capacitance vessels filled. Accordingly, forearm blood flow was calculated from the initial slope of the forearm volume-time plot before inflow reduction (figure 1).
Forearm vascular resistance was calculated from the ratio of the pressure gradient across the forearm (mean arterial minus mean venous pressure) divided by forearm blood flow. Measurements were recorded at 20 sec intervals throughout the period of study.
Peripheral venous tone was determined with use of the acute occlusion technique."' Acute occlusion of venous return was achieved by sphygmomanometric cuff, and venous tone was calculated as the ratio of the initial increment in venous pressure to the initial increase in forearm (primarily venous) volume. A fundamentally important index of peripheral venous hemodynamics is the change in volume of the venous bed due to an intervention, in this case administration of nifedipine. We measured this volume change at the prevailing venous pressure rather than at an elevated pressure, such as 30 mm Hg, as has sometimes been done, since response to nifedipine is relatively slow and it was not feasible to occlude venous return for 30 min.
Since in pilot studies we ascertained that the repeated venous occlusion required for measurement of flow, resistance, and tone invalidated trend monitoring of forearm volume with the same plethysmograph, an independent plethysmograph was placed on the contralateral arm, which was otherwise uninstrumented, for serial forearm volume determinations. This is very similar to one of the equilibration methods used by Mason and Braunwald'5 to assess the effects of drugs on the volume of the capacitance vessels.
Patients were studied in the supine position with both arms placed horizontally and the forearms at midchest level in a 700 F room. Fully rotating fluoroscopic-cineangiographic equipment was used (Siemens Angioskop), permitting the entire study to be conducted without movement or rotation of the patient. Mercury-in-rubber strain gauges (Hokanson) were placed around both midforearms of each patient, the arms being comfortably supported so as to avoid extraneous pressures on the strain gauges. A sphygmomanometric cuff was placed on the upper left arm to permit rapid venous occlusion at 30 to 40 mm Hg. A pediatric sphygmomanometric cuff was placed around the left wrist for inflation to suprasystolic pressure at least 1 min before each venous occlusion measurement to exclude the hand circulation (the characteristics of which differ from those of the 111 OPi i, i; 
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forearm) from the vascular system studied. Left forearm venous pressure was monitored through an 18-gauge, 3 inch catheter introduced into a large forearm vein and advanced so that its tip was at the level of the strain gauge. A heparin-flush system was used to maintain patency of the venous lines. Mean arterial pressure was monitored continuously via the side port of the femoral arterial sheath. Data from the two plethysmographic channels, venous pressure, mean arterial pressure, and an electrocardiogram were recorded simultaneously on photosensitive paper (Honeywell 1858 Visicorder). Plethysmographic output was calibrated in volume percent change, i.e., milliliters'of increase in blood volume per 100 ml of total forearm tissue enclosed between the venous occlusion cuff and wrist cuff. Since the fractional change in forearm volume equals the fractional change in resistance of the strain gauge, the volume calibration factor is available electronically from the instrumentation. Parameters calculated from this relative volume are designated here as being "normalized" to forearm volume and bear the subscript "n." The actual volume of each patient's forearm between the delimiting cuffs was measured before the procedure by the volume displacement principle. Specifically, the arm was immersed in a column of water and the displaced water volume was measured. Basal forearm volume was related to the plethysmographic data to permit calculation of the absolute volume increase of the forearm. Hence, "absolute" hemodynamic parameters, indexed by the subscript "a," were calculated. Use of absolute hemodynamic parameters was developed specifically to permit comparison of peripheral and central hemodynamic variables, and to provide data in units that are physiologically meaningful.
Forearm blood flow, [measured in ml/(100 ml x min)] was calculated as the initial rate of increase in forearm volume after venous occlusion, measured as the tangent to the curve recorded via the plethysmograph (figure 1). Forearm blood flowa (ml/ min) was calculated by multiplying forearm blood flown by basal forearm volume. Forearm vascular resistance5 was derived as the ratio between the pressure gradient across the forearm and the forearm blood flow, (mm Hg x 100 ml x min/ml).
Forearm vascular resistancea (mm Hg x min/ml) was derived analogously. Forearmn venous tonen (mm Hg x 100 ml/ml) was calculated from the ratio of the tangents to the initial venous pressure and venous volume curves (figure 1). Forearm venous tone5 was expressed in millimeters of mercury per milliliter.
Forearm volume changen (ml/100 ml of forearm tissue) was measured directly from the right arm plethysmograph as volume percent change from baseline. Forearm volume changea was expressed in milliliters.
The fraction of total blood flow perfusing the forearm was derived from the ratio of forearm blood flowa to cardiac output.
This parameter was developed to quantitate the change in the fraction of total cardiac output perfusing the forearm in comparison with other vascular beds in deference to the differential response of different arterial beds to pharmacologic influences.
The accuracy of calculated forearm blood flOwa is limited primarily by the inherent inaccuracies of measuring forearm blood flown by the strain-gauge technique, with its assumptions of a cylindrical forearm. Although the fraction of total cardiac output perfusing the forearm is therefore limited in its precision, the assessment of changes in this fraction due to nifedipine have reasonable validity since forearm shape is not measurably altered by pharmacologic intervention. Statistical analysis. Changes in hemodynamic parameters after the intervention were evaluated with use of the paired t test. Intergroup differences with respect to baseline values and differences in responses to the intervention between patients with normal and those with abnormal left ventricular function were assessed with Student's t test.
Results
Clinical characteristics. Thirty-two patients (30 men and two women) with an average age of 54.8 years (range 36 to 70) were studied. Twenty-one received nifedipine and 11 placebo. Five patients who received nifedipine did not take part in the randomization protocol at the request of the referring physician because he felt the clinical information obtained would greatly benefit patient management.
Patients were categorized into two groups with the use of previously established criteria.' Group 1 had normal left ventricular function, and group 2 had abnormal function, as determined by the presence of any of the following: aneurysm, marked segmental hypokinesis or more severe wall motion abnormality, ejection fraction less than 45%, end-diastolic volume index greater than 90 ml/m2, or end-diastolic pressure greater than 20 mm Hg. Among the 21 patients receiving nifedipine, left ventricular function was normal in five (group 1) and abnormal in 16 (group 2). In the patients receiving placebo, left ventricular function was normal in three and abnormal in eight. Patients with normal and abnormal ventricular function were equally represented in the treated and untreated groups. Among the 24 patients having abnormal left ventricular function, significant wall motion abnormalities were present in 21, ejection fraction was less than 45% in 12, end-diastolic pressure was 20 mm Hg or more in 12, end-diastolic volume index was 90 ml/ m2or more in seven, and aneurysms were present in five. Average number of criteria met in the abnormal function group was 2.38. No complications were associated with the administration of nifedipine or placebo or with the catheterization procedure. Peripheral arterial and venous pressures declined significantly after nifedipine, while heart rate remained unchanged ( figure 3) . Thus, mean arterial pressure declined by 11.8% (p < .00001), while forearm venous pressure declined by 8.4% (p = .027). average of 11.6% (p = .023), whil end-diastolic pressure was not sigr after nifedipine ( figure 4 ). Left ventr ic volume decreased 4.2% (p < .0 Cardiac output increased by 9.3% systemic vascular resistance decline .00001). The ratio of total forearm t cardiac output increased by 13.2%o Differential effects of nifedipine in si vs impaired left ventricular function Hemodynamic parameters in nife4 tients stratified according to normal left ventricular function are tabulate ARVEDP lished studies on derived indexes of left ventricular systolic and diastolic function emphasize extensive differences between these two subsets of patients. ' Our investigation, however, was focused primarily on the response of peripheral vascular hemodynamics to nifedipine. In this study, the only baseline parameters differing significantly between the two groups were forearm vascular resistance and left ventricular end- In patients with abnormal left ventricular function, nifedipine changed peripheral arterial hemodynamics significantly, while parameters of peripheral venous hemodyriamics remained unchanged. Thus, forearm blood flown increased by an average of 30.7% (p < .0004), while forearm vascular resistance. declined by an average of 36.3% (p < .0002). Parameters of net venous hemodynamics showed negligible change.
In patients with abnormal left ventricular function, mean arterial pressure declined by an average of 12.9% (p < .00002) and forearm venous pressure declined by 10.0% (p = .034). Heart rate was not changed. Left ventricular end-diastolic pressure declined by an average of 14.2% (p -.0 18), while right ventricular end-diastolic pressure remained unchanged. Left ventricular end-diastolic volume decreased 4.8% (p < .05) and cardiac output increased by 10 . 1% (p < .002), while systemic vascular resistance declined by 23.9% (p < .0002). The ratio of total forearm blood flow to total cardiac output increased by an average of 19.6% (p < .01).
In contrast to the results observed in group 2 patients, parameters of both central and peripheral hemodynamics were minimally changed after nifedipine in patients with normal left ventricular function. Statistically significant changes were observed only for mean arterial pressure, which declined by an average of 8.4% (p = .039), and systemic vascular resistance, which declined by an average of 21.1% (p .017). None of the derived parameters of peripheral vascular hemodynamics were significantly changed after nifedipine in this group of patients with normal left ventricular function.
Although the hemodynamic effects of nifedipine were more striking in patients with abnormal than in those with normal left ventricular function, the distinction was statistically significant only for forearm vascular resistance (figure 2) and for the ratio of total forearm blood flow to total cardiac output. Changes in both of these parameters were greater in patients with abnormal than in those with normal left ventricular function.
The time course of effects of nifedipine on all parameters of central and peripheral hemodynamics was consistent in all patients. Hemodynamic effects commenced 5 min after sublingual administration of 20 mg nifedipine, increased progressively, and reached a plateau at between 10 and 25 min ( figure 5 ).
Discussion
Nifedipine exerts substantial effects on left ventricular function, including the reduction of elevated filling pressure in certain patients, as demonstrated previously by our group' and again in the current study. However, in man it is difficult to distinguish direct pharmacologic effects on the heart from those induced secondarily via alteration of peripheral vascular hemodynamics. Several investigators have suggested that the prominent influence of nifedipine on left ventricular performance is indeed mediated through its peripheral vasodilatory effect. [17] [18] [19] Accordingly, our study was specifically designed to define the effects of nifedipine on the peripheral vascular system and to elucidate mechanisms responsible for the reduction of left ventricular filling pressure observed in certain patients after administration of nifedipine. The indexes used in our study were selected to provide insight into the responses of the peripheral venous system after nifedipine, and particularly to discern any indication of pe-Vol. 69, No. 5, May 1984 ripheral "venous pooling" which, if it occurred, might explain the reduction in left ventricular filling pressures in certain patients after nifedipine.
Review of the peripheral effects of nifedipine. The results of our direct measurements of the changes in peripheral arterial hemodynamics after administration of nifedipine are consistent with the limited data previously reported. Thus, a 67% increase in blood flow in the calf was reported by Mostbeck et al.' in 15 normal human subjects after administration of nifedipine (20 mg sublingually). Likewise, Pederson et al.9 observed a 35% increase in forearm blood flow in 11 hypertensive patients after nifedipine (10 mg sublingually), in association with a 30% reduction in forearm vascular resistance. Robinson et al.`reported a 60% increase in forearm blood flow after brachial arterial injection of nifedipine in healthy subjects. Concordantly, in our study, forearm blood flow increased in all patients receiving nifedipine by an average of 26%, while forearm vascular resistance declined by an average of 32%. In our group of patients with impaired left ventricular function, forearm blood flow increased by 31% and forearm vascular resistance fell by 36%. The change in forearm vascular resistance observed in patients with abnormal left ventricular function differed significantly from that in patients with normal left ventricular function.
The increase in peripheral blood flow observed in our study is concordant with the increase in total cardiac output, and the reduction of measured peripheral vascular resistance parallels the decline in calculated systemic vascular resistance. Our results suggest that diminution of peripheral vascular resistance is the primary effect of the drug in vivo and that the improved left ventricular systolic performance is secondary to reduction of afterload. The effects of nifedipine on the various arterial beds is heterogeneous, as evidenced by the change in the ratio of absolute forearm blood flow to total cardiac output documented in this study. The increase in the value of this ratio after administration of nifedipine indicates a disproportionate "shunting" of the increase in total cardiac output to the forearm, this effect being particularly prominent in patients with impaired left ventricular function.
No net change in peripheral venous hemodynamics was observed after nifedipine in the present studies. Our parameter of forearm volume change measured a mean increase of 0.06%, compared with the greater than 1% volume increase in response to sublingual nitroglycerin noted by Mason and Braunwald. 15 Thus, although the interpatient variation in change in forearm volume after nifedipine is large compared with the 969 mean change, these values are quantitatively small and clearly not significant. Little comparable data are available in the literature concerning the effects of nifedipine on the peripheral venous system in man. Robinson et al., 0 studying the response of hand veins in normal subjects, observed that nifedipine blocked potassium-induced venoconstriction but failed to relax veins already constricted by noradrenaline. Using technetium-labeled albumin, Mostbeck et al.8 examined the total body distribution in three patients without heart disease. In their study, nifedipine (1 mg iv) induced an average 10% reduction in volume, although the change was not statistically significant. In a separate study Mostbeck et al.'3 performed "capacitance plethysmography" in five healthy volunteers and observed an insignificant increase in the capacity of the forearm. Braunwald2" asserted that calcium channel-blocking drugs relaxed smooth muscle in the arteriolar bed to a greater extent than in the venous bed, and recommended that these drugs be considered as predominant arterial vasodilators. Our study confirmed that net changes in parameters of venous hemodynamics (particularly forearm venous tone and forearm volume) were negligible after nifedipine, both for the set of all subjects and for subsets defined by left ventricular function.
Mechanism for lowered filling pressure. Thus, the decline in left ventricular filling pressure observed after nifedipine in certain subjects does not appear to be attributable to a nitroglycerin-like venous pooling effect, at least in the peripheral musculocutaneous vasculature. Two mechanisms exist by which left ventricular diastolic pressure may be reduced.`7 First, diastolic pressure may be reduced for any given diastolic volume (increased compliance). Second, diastolic volume and, pari passu, pressure may be decreased concordantly. In the latter context, left ventricular volume may be reduced by "retrograde displacement" (venous pooling), or by augmented antegrade emptying (increased ejection fraction). Previous work from this laboratory' indicates that indexes of left ventricular diastolic relaxation and intrinsic diastolic chamber stiffness are not altered after administration of nifedipine, while the present study suggests the absence of venous pooling in response to the drug. These findings indicate that the diminished end-diastolic left ventricular pressures and volumes observed after administration of nifedipine in certain patients are attributable predominantly to augmented left ventricular systolic emptying. The increased cardiac output and ejection fraction observed in the present study supports this conclusion. Likewise, Miller et al. 17 as-serted that as systemic flow is increased independently of preload, ventricular filling pressure will decrease. Thus, ". . . systolic unloading . . . would appear to be the most important [mechanism] in explaining lowered right (as well as left) sided filling pressures occurring concomitant with increased cardiac output."'7 Based on the results of the present study, nifedipine appears to induce relaxation of arteriolar smooth muscle, which results in a decline in forearm (and systemic) vascular resistance, leading secondarily to an increase in forearm (and, by inference, total body) blood flow. This augmentation of cardiac output and ejection volume results in a reduction in left ventricular filling pressure without concomitant alteration of venous hemodynamics or left ventricular chamber compliance characteristics. The greater reduction in end-diastolic left ventricular pressure in patients with impaired ventricular function is attributed to the greater reduction in peripheral resistance in these patients; this, in turn, may be related to the higher levels of baseline peripheral vascular resistance in patients with impaired ventricular function.
Study limitations. Certain qualifications with regard to the measures of peripheral vascular hemodynamics used in our study should be recognized. We studied net rather than primary actions of nifedipine. Furthermore, only one peripheral vascular bed was examined, namely that of the forearm. It was our purpose to define the effects of nifedipine in the intact human, which required that both primary direct effects and secondary reflex actions be measured to establish the net clinical effect. A potent arteriolar smooth muscle vasodilating agent such as nifedipine might well be expected to exert some similar action on the smooth muscle of the venous vasculature, and initial hemodynamic changes in resistance, pressure, and heart rate would be expected to elicit sympathetic reflex responses both in other territories of the peripheral circulation and in the heart. Although these differential responses have been identified in isolated vascular and heart preparations,2' 22 such distinctions are difficult in the clinical situation,'7 23 and would require complex concomitant use of sympathetic and/or parasympathetic blocking agents. Suggestion of an adrenergic reflex response exists in the form of a positive correlation between change in cardiac index and change in plasma norepinephrine levels after nifedipine administration. 24 Although we recognize that nifedipine may have exerted an initial venous pooling effect that was subsequently masked by reflex sympathetic venoconstriction, as occurs after administration of amyl nitrite,25 such a response would not alter our conclusions since the net 970 CIRCULATION observed effect was of a reduction in left ventricular filling pressure at a time when venous pooling was not observed.
It is also important to recognize that the present study is restricted to the response of the forearm vasculature to nifedipine and that the response of other vascular beds, particularly the splanchnic bed, may differ both qualitatively and quantitatively.21 22Furthermore, such a differential response may be additionally modified in the presence of congestive heart failure. 23 Indeed, the present study demonstrates that the effects of nifedipine on the peripheral arterial system vary in the different vascular beds, as attested to by the increase in the ratio of the forearm blood flow to total cardiac output after administration of nifedipine. While the vasculature of all four limbs might be expected to react similarly, evaluation of the response of the visceral circulation in the clinical situation is difficult.
Furthermore, peripheral vascular hemodynamics, particularly in the venous circulation, may be modified by different gravitational conditions, and thus may vary when studies are conducted in patients in the supine as compared with in the erect position. Since the plethysmographic measurements reported here were obtained during complete cardiac catheterization procedures, it was not feasible to investigate these varied gravitational influences. Long-term hemodynamic responses were not evaluated in this study, and the possibility of tachyphylaxis has not been excluded. Results of a small study6 indicate that the beneficial hemodynamic effects of nifedipine in the treatment of chronic congestive heart failure are sustained for at least 2 months. Clinical implications. The findings of our study have important implications with regard to the clinical use of nifedipine. Mean arterial pressure declined by an average of 13% in patients with impaired left ventricular function and by 8% in those with normal function. Concomitantly, left ventricular end-diastolic pressure fell by 14%, while cardiac output increased by 10% in patients with left ventricular dysfunction. These potentially beneficial effects appear to be mediated via the reduction of peripheral arterial resistance, as reflected in the 24% decline in systemic vascular resistance we observed. These results imply a particularly enticing potential for management of patients with congestive heart failure, in whom enhancement offorward cardiac output and reduction of left ventricular filling pressures and pulmonary vascular pressures might be anticipated. The absence of a reduction in left ventricular end-diastolic pressure in our relatively small group of patients with normal left ventricular function suggests a degree of safety for the use of nifedipine in these patients, in whom a decline in filling pressure might be deleterious, with a reduction of cardiac output in keeping with the Frank-Starling mechanism. The hemodynamic response can be easily assessed since the action of nifedipine is rapid, with onset of effect 5 min after sublingual administration and maximum effect within 20 to 30 min.
The results of our study are also important with regard to the mechanisms of certain side effects of nifedipine, most of which are attributable to the vasodilatory effect of the drug. 19 Thus, cutaneous flushing is presumably attributable to arteriolar vasodilatation with consequent augmentation of cutaneous blood flow. The variable occurrence and distribution of flushing is consistent with our finding of the heterogeneity of the arteriolar response to nifedipine. Peripheral edema, generally observed in dependent limbs after long-term administration of nifedipine, is probably attributable to the accumulation of interstitial rather than of intravascular fluid and may be related causally to the increased arteriolar blood flow in the absence of concomitant reduction of venous tone.
Baseline peripheral hemodynamic measurements. The baseline peripheral hemodynamic data (i.e., before intervention) from our study compare well with those of other investigators who used similar techniques, and represent a much larger number of patients than is available in the literature. The parameters in table 2, which were normalized to forearm volume and tabulated separately for patients with normal and impaired left ventricular function, were measured with techniques similar to those reported by other investigators. 15. 16, 26, 27 Baseline forearm vascular resistance was higher in patients with poor left ventricular function than in those with normal function. Although a trend toward greater forearm blood flow in patients with normal left ventricular function was evident, the difference was statistically insignificant. Likewise, a trend toward higher forearm venous tone was discernible in patients with impaired left ventricular function, but was not statistically significant.
The absolute (i.e., not normalized to forearm volume) peripheral hemodynamic parameters are presented in tables 1 through 3. There are no comparable data in the literature for comparison. These absolute parameters were developed specifically to permit comparison with global hemodynamic change (e.g., cardiac output and calculated systemic vascular resistance) and to allow estimation of heterogeneity of the response of different vascular beds. The absolute parameters have a more direct physiologic meaning than do Vol. 69, No. 5, May 1984 971 the normalized ones, as evidenced by their corresponding units of measurement.
In conclusion, our results, obtained by direct measurement of peripheral vascular hemodynamics, confirm that nifedipine produces prominent dilatation of the peripheral arteriovascular bed in man, with concomitant reduction of systemic vascular resistance. This effect comprises the predominant mechanism for the observed augmentation of cardiac output. The reduction in left ventricular filling pressure after administration of nifedipine is not attributable to peripheral venous pooling, but is secondary to the improved left ventricular systolic emptying facilitated by reduction in left ventricular afterload, particularly in patients with impaired left ventricular function.
